Silphium Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Silphium Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-131,000	Closed	-$6.07M	–	110
2019 Q2	$6.07M	Buy	+131,000	New	+$3.68M	1.72%	19

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Silphium Asset Management's ARRY Position: Q3 2019 in Review

Silphium Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 131,000 shares — an estimated $6.07M sold.

Silphium Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $6.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Silphium Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Silphium Asset Management sold 131,000 Array Biopharma Inc shares in Q3 2019, an estimated $6.07M.
Silphium Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Silphium Asset Management's Array Biopharma Inc position peaked at $6.07M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Silphium Asset Management's 13F filing for Q3 2019, filed 30 Jan 2025.